Balyasny Asset Management LLC Infinity Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $2,057 - $5,929	3,488 Added 20.37%	20,611 $25,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $8,390 - $20,547	17,123 New	17,123 $11,000
Q2 2021 Aug 16, 2021	SELL	$2.66 - $3.47 $44,882 - $58,549	-16,873 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $33,408 - $90,439	16,873 New	16,873 $54,000
Q1 2018 May 15, 2018	SELL	$1.8 - $2.74 $34,785 - $52,950	-19,325 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.22 - $3.73 $23,576 - $72,082	19,325	19,325 $39,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.